Skip to content

Comparison of the Visual Performance After Implantation of Multifocal Lens

Comparison of the Visual Performance After Implantation of a Trifocal Intraocular Lens(AT Lisa Tri 839MP) and Two Bifocal Intraocular Lenses(ReSTOR +2.5/+ 3.0D and Diff-aay)

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03586271
Enrollment
60
Registered
2018-07-13
Start date
2018-08-02
Completion date
2019-02-01
Last updated
2018-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intraocular Lens

Brief summary

This is a prospective, consecutive, nonrandomized,comparative study. Comparison of the Visual Performance After Implantation of a Trifocal Intraocular Lens and Two Bifocal Intraocular Lenses

Detailed description

Multifocal intraocular lenses were introduced in the 1980s and have the benefit of promoting near and far vision simultaneous. However, these multifocal lenses have the disadvantages, including lower contrast sensitivity(CS) and visual discomfort, such as halos, glares and starburst, et al. Therefore, careful patient selection is crucial to achieve good postoperative results. The purpose of this study was to compare the visual outcomes and subjective visual quality between bifocal intraocular Lens(ReSTOR +2.5/+ 3.0D and Diff-aay) and trifocal intraocular Lens(AT Lisa tri 839MP). This prospective, nonrandomized, consecutive, comparative study included the assessment of 60 patients implanted with multifocal intraocular lens. visual acuity was tested in all cases. Ophthalmological evaluation included the measurement of uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), uncorrected near visual acuity (UNVA), and uncorrected intermediate visual acuity (UIVA), the analysis of contrast sensitivity (CS), visual defocus curve, spectacle independence, patient satisfaction, residual sphere, spherical equivalent (SE), cylinder and complications.

Interventions

PROCEDUREtrifocal lens

phacoemusification + trifocal lens(AT Lisa tri 839MP) implantation

PROCEDUREbifocal lens 1

phacoemusification +bifocal lens(Diff-aay) implantation

PROCEDUREbifocal lens 2

phacoemusification +bifocal lens (ReSTOR +3.0D) implantation

PROCEDUREbifocal lens 3

phacoemusification +bifocal lens (ReSTOR +2.5D) implantation

Sponsors

Aier School of Ophthalmology, Central South University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
40 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* cataract

Exclusion criteria

* existence of any corneal disease; * previous eye surgery; * illiteracy; * previous refractive surgery; * expected postoperative corneal astigmatism more than 1.00D; * higer-order aberration more than 0.3; * spherical aberration more than 0.3μm; * intraoperative or postoperative complications.

Design outcomes

Primary

MeasureTime frameDescription
Uncorrected distance visual acuity3 months after surgeryUncorrected distance visual acuity (4m) were measured using the reading table model of the Early Treatment Diabetic Retinopathy Study charts (ETDRS; Vector Vision, Ltd, Greenville, OH, USA).
Uncorrected near visual acuity3 months after surgeryUncorrected near visual acuity (40cm) were measured using the reading table model of the Early Treatment Diabetic Retinopathy Study charts (ETDRS; Vector Vision, Ltd, Greenville, OH, USA).
Uncorrected intermediate visual acuity3 months after surgeryUncorrected intermediate visual acuity (60cm) were measured using the reading table model of the Early Treatment Diabetic Retinopathy Study charts (ETDRS; Vector Vision, Ltd, Greenville, OH, USA).

Other

MeasureTime frameDescription
Quality of vision3 months after surgeryQuality of vision was measured using the National Eye Institute Visual Function Questionnaire (NEI VFQ)-25. The NEI-VFQ was developed at the RAND under the sponsorship of the NEI; it provides a self-reported measure of visual function.

Countries

China

Contacts

Primary ContactHua Fan
fanhua1116@163.com+8618988761617
Backup ContactWensheng Li
drlws@qq.com+8618650424985

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026